Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Bonnetain

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Clinical Colorectal Cancer|November 13, 2017
Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective StudyAnthony Turpin, Sophie Paget-Bailly, Anne Ploquin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 20, 2015
Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized TrialAntoine Barbieri, Amélie Anota, Thierry Conroy, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 20, 2019
Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncologyFrancesco Cottone, Nina Deliu, Gary S Collins, et al.
Health and Quality of Life Outcomes|December 13, 2018
Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured reviewAhmad Ousmen, Célia Touraine, Nina Deliu, et al.
Leukemia & Lymphoma|August 29, 2014
The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registryMylène Dandoit, Morgane Mounier, Julien Guy, et al.
Journal of Hepatology|November 27, 2012
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinomaMomar Diouf, Thomas Filleron, Jean-Claude Barbare, et al.
BMC Cancer|June 21, 2017
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC studyQuentin Jacquinot, Nathalie Meneveau, Marion Chatot, et al.
BMJ Open|June 12, 2019
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroupNicolas Kerckhove, Jérome Busserolles, Trevor Stanbury, et al.
Breast (Edinburgh, Scotland)|August 7, 2012
Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year studySéverine Guiu, Laurent Arnould, Franck Bonnetain, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2011
Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 yearGilles Crehange, Philippe Maingon, Melanie Gauthier, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Clinical Colorectal Cancer|November 13, 2017
Clinical Relevance of Alternative Endpoints in Colorectal Cancer First-Line Therapy With Bevacizumab: A Retrospective StudyAnthony Turpin, Sophie Paget-Bailly, Anne Ploquin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|December 20, 2015
Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized TrialAntoine Barbieri, Amélie Anota, Thierry Conroy, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 20, 2019
Modeling strategies to improve parameter estimates in prognostic factors analyses with patient-reported outcomes in oncologyFrancesco Cottone, Nina Deliu, Gary S Collins, et al.
Health and Quality of Life Outcomes|December 13, 2018
Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured reviewAhmad Ousmen, Célia Touraine, Nina Deliu, et al.
Leukemia & Lymphoma|August 29, 2014
The heterogeneity of changes in incidence and survival among lymphoid malignancies in a 30-year French population-based registryMylène Dandoit, Morgane Mounier, Julien Guy, et al.
Journal of Hepatology|November 27, 2012
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinomaMomar Diouf, Thomas Filleron, Jean-Claude Barbare, et al.
BMC Cancer|June 21, 2017
A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC studyQuentin Jacquinot, Nathalie Meneveau, Marion Chatot, et al.
BMJ Open|June 12, 2019
Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroupNicolas Kerckhove, Jérome Busserolles, Trevor Stanbury, et al.
Breast (Edinburgh, Scotland)|August 7, 2012
Pathological response and survival after neoadjuvant therapy for breast cancer: a 30-year studySéverine Guiu, Laurent Arnould, Franck Bonnetain, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2011
Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 yearGilles Crehange, Philippe Maingon, Melanie Gauthier, et al.
Pageof 17